Homocysteine as a predictive factor for hip fracture in older persons
- PMID: 15141042
- DOI: 10.1056/NEJMoa032739
Homocysteine as a predictive factor for hip fracture in older persons
Abstract
Background: The increased prevalence of osteoporosis among people with homocystinuria suggests that a high serum homocysteine concentration may weaken bone by interfering with collagen cross-linking, thereby increasing the risk of osteoporotic fracture. We examined the association between the total homocysteine concentration and the risk of hip fracture in men and women enrolled in the Framingham Study.
Methods: We studied 825 men and 1174 women, ranging in age from 59 to 91 years, from whom blood samples had been obtained between 1979 and 1982 to measure plasma total homocysteine. The participants in our study were followed from the time that the sample was obtained through June 1998 for incident hip fracture. Sex-specific, age-adjusted incidence rates of hip fracture were calculated for quartiles of total homocysteine concentrations. Cox proportional-hazards regression was used to calculate hazard ratios for quartiles of homocysteine values.
Results: The mean (+/-SD) plasma total homocysteine concentration was 13.4+/-9.1 micromol per liter in men and 12.1+/-5.3 micromol per liter in women. The median duration of follow-up was 12.3 years for men and 15.0 years for women. There were 41 hip fractures among men and 146 among women. The age-adjusted incidence rates per 1000 person-years for hip fracture, from the lowest to the highest quartile for total homocysteine, were 1.96 (95 percent confidence interval, 0.52 to 3.41), 3.24 (0.97 to 5.52), 4.43 (1.80 to 7.07), and 8.14 (4.20 to 12.08) for men and 9.42 (5.72 to 13.12), 7.01 (4.29 to 9.72), 9.58 (6.42 to 12.74), and 16.57 (11.84 to 21.30) for women. Men and women in the highest quartile had a greater risk of hip fracture than those in the lowest quartile--the risk was almost four times as high for men and 1.9 times as high for women.
Conclusions: These findings suggest that the homocysteine concentration, which is easily modifiable by means of dietary intervention, is an important risk factor for hip fracture in older persons.
Copyright 2004 Massachusetts Medical Society
Comment in
-
Homocysteine and osteoporotic fractures--culprit or bystander?N Engl J Med. 2004 May 13;350(20):2089-90. doi: 10.1056/NEJMe048030. N Engl J Med. 2004. PMID: 15141048 No abstract available.
-
Homocysteine as a predictive factor for hip fracture in older persons.N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. doi: 10.1056/NEJM200409023511017. N Engl J Med. 2004. PMID: 15342813 No abstract available.
-
Homocysteine as a predictive factor for hip fracture in older persons.N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. N Engl J Med. 2004. PMID: 15352274 No abstract available.
-
Homocysteine as a predictive factor for hip fracture in older persons.N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. N Engl J Med. 2004. PMID: 15352275 No abstract available.
Similar articles
-
Homocysteine levels and the risk of osteoporotic fracture.N Engl J Med. 2004 May 13;350(20):2033-41. doi: 10.1056/NEJMoa032546. N Engl J Med. 2004. PMID: 15141041
-
Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study.J Bone Miner Res. 2007 May;22(5):747-56. doi: 10.1359/jbmr.070210. J Bone Miner Res. 2007. PMID: 17295607 Clinical Trial.
-
Serum retinoids and beta-carotene as predictors of hip and other fractures in elderly women.J Bone Miner Res. 2005 Jun;20(6):913-20. doi: 10.1359/JBMR.050112. Epub 2005 Jan 24. J Bone Miner Res. 2005. PMID: 15883630
-
Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study.Am J Med. 2006 May;119(5):426-33. doi: 10.1016/j.amjmed.2005.10.048. Am J Med. 2006. PMID: 16651055
-
Hip fractures in men.Osteoporos Int. 1996;6 Suppl 3:48-51. doi: 10.1007/BF01623765. Osteoporos Int. 1996. PMID: 8931047 Review. No abstract available.
Cited by
-
Taurine/chenodeoxycholic acid ratio as a potential serum biomarker for low vitamin B12 levels in humans.Br J Nutr. 2024 Sep 28;132(6):712-724. doi: 10.1017/S0007114524002022. Epub 2024 Oct 4. Br J Nutr. 2024. PMID: 39364656 Free PMC article.
-
Association of Methylenetetrahydrofolate Reductase rs1801133 Polymorphism with osteoporosis and fracture risk in Taiwan.Int J Med Sci. 2024 Aug 19;21(12):2261-2271. doi: 10.7150/ijms.97524. eCollection 2024. Int J Med Sci. 2024. PMID: 39310265 Free PMC article.
-
Spinal osteoarthritis is a risk of vertebral fractures in postmenopausal women.Sci Rep. 2024 Feb 12;14(1):3528. doi: 10.1038/s41598-024-53994-1. Sci Rep. 2024. PMID: 38347047 Free PMC article.
-
Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis.Korean J Intern Med. 2024 Jan;39(1):148-159. doi: 10.3904/kjim.2023.292. Epub 2023 Dec 22. Korean J Intern Med. 2024. PMID: 38145616 Free PMC article.
-
Association between dietary folate intake and bone mineral density in a diverse population: a cross-sectional study.J Orthop Surg Res. 2023 Sep 14;18(1):684. doi: 10.1186/s13018-023-04188-4. J Orthop Surg Res. 2023. PMID: 37710267 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical